The Next Generation Colposcope with an Advanced Cervical Scan

DYSISmap is an adjunctive technology to assist colposcopy

The DYSIS Colposcope is a high resolution digital colposcope with an adjunctive map. The DYSISmap is generated by a proprietary technology that measures the aceto-whitening reaction and summarises it in the form of an intuitive map. The DYSISmap is overlaid on the live image of the cervix to help with the identification of the most relevant biopsy sites.

5 December, 2012

Innovation Award Finalist

5 December 2012 Scotland celebrates world class life sciences sector. A number of Scotland’s most dynamic life sciences companies and business leaders have been shortlisted for the prestigious Scottish Enterprise Life Sciences Awards 2013. Successful nominations have been named in seven award categories which celebrate […]

More >

2 November, 2012

Interview with DYSIS CEO

2 November 2012 Alastair Atkinson is interviewed by News Medical magazine. For the transcript, please goto :

More >

3 September, 2012

Maggie Philbin to Chair DYSIS Symposium

DYSIS Medical Ltd (DYSIS or the Company)   Maggie Philbin to Chair DYSIS Symposium   DYSIS Medical will attend the Preventive Health Conference in London on September 20th, 2012 and will host a symposium chaired by Maggie Philbin. Edinburgh – 3rd September 2012 – DYSIS […]

More >

1 September, 2012

NHSCSP Guidelines include DYSIS implementation

DYSIS included in NHSCSP Guidelines  NHS Cervical Screening Programme has updated its guidelines to include an implementation guide for DYSIS. Edinburgh – 1st September 2012 – DYSIS Medical Ltd, the medical devices company in female health, today announced that its cervical cancer screening colposcopy technology […]

More >

12 August, 2012

NICE recommends DYSIS

Report shows product as clinically and cost-effective Edinburgh – August 2012 – DYSIS Medical Ltd, the medical devices company in female health, announces that the National Institute for Health and Clinical Excellence (‘NICE’) has today published positive diagnostics guidance recommending its DYSIS cervical cancer screening […]

More >

31 March, 2012

University of Karolinska becomes DYSIS Reference Centre

DYSIS announces new collaboration with the prestigious University of Karolinska DYSIS Medical is delighted to announce a new collaboration with the University of Karolinska, Sweden.  The new partnership has so far seen the installation of a DYSIS unit for the University’s use in its main […]

More >

28 March, 2012

DYSIS achieves Clinical and Cost Benefits

DYSIS Medical Ltd (DYSIS or the Company) DYSIS Cervical Cancer Screening Tool Achieves Clinical and Cost Benefits to Patients Study commissioned by NIHR HTA programme on behalf of NICE highlights sensitivity and benefits of DYSIS over conventional methods Edinburgh – 28 March 2012 – DYSIS […]

More >

6 February, 2012

Clinical Investigation Results

DYSIS Clinical Investigation Results. DYSISmedical, the company behind the world’s first digital mapping colposcope, has announced that their DYSIS product has been the subject of a clinical investigation, with results that demonstrate its capacity to detect pre-cancerous lesions of the cervix. A newly published article, […]

More >